Source: Radiological Society of North America, June 2025
Recent advances in AI and machine learning hold promising potential across all aspects of health care, from diagnosis to treatment planning and response evaluation. Machine learning can predict response to immunotherapy in patients with metastatic melanoma, potentially speeding effective care for an often deadly
disease, according to research supported by an RSNA R&E Foundation grant. Melanoma is the most serious skin cancer due to its potential to spread to other parts of the body like the brain, liver and lungs. Five-year survival rates are excellent if the disease is diagnosed and treated at an early stage but fall significantly once the cancer has metastasized.